We evaluated the IDH2 status in 96 DNA samples from AML patients with the three methods and we observed that PNA-PCR clamping was in accordance with ddPCR results, in contrast, there was a significant disagreement between Sanger sequencing and the ddPCR results. This evidence concerns the gene IDH2 and acute myeloid leukemia.